199 related articles for article (PubMed ID: 21874059)
21. A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Sakellari I; Angelopoulou M; Tsopra O; Dervenoulas I; Tsirigotis P; Spyridonidis A; Liga M; Tsionos K; Anargyrou K; Pouli A; Anagnostopoulos A
Ann Hematol; 2015 Oct; 94(10):1733-40. PubMed ID: 26141369
[TBL] [Abstract][Full Text] [Related]
22. Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study.
Tsirigotis P; Triantafyllou K; Girkas K; Giannopoulou V; Ioannidou E; Chondropoulos S; Kalli T; Papaxoinis G; Pappa V; Papageorgiou E; Economopoulos T; Ladas SD; Dervenoulas J
Bone Marrow Transplant; 2008 Sep; 42(5):337-43. PubMed ID: 18560408
[TBL] [Abstract][Full Text] [Related]
23. Colchicine mouth washings to improve oral mucositis in patients with hematological malignancies: a clinical trial.
Garavito AA; Cardona AF; Reveiz L; Ospina E; Yepes A; Ospina V
Palliat Support Care; 2008 Dec; 6(4):371-6. PubMed ID: 19006592
[TBL] [Abstract][Full Text] [Related]
24. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
Radtke ML; Kolesar JM
J Oncol Pharm Pract; 2005 Sep; 11(3):121-5. PubMed ID: 16390600
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation: a prospective clinical study.
de Paula Eduardo F; Bezinelli LM; da Graça Lopes RM; Nascimento Sobrinho JJ; Hamerschlak N; Correa L
Hematol Oncol; 2015 Sep; 33(3):152-8. PubMed ID: 24519448
[TBL] [Abstract][Full Text] [Related]
26. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation.
Ohbayashi Y; Imataki O; Ohnishi H; Iwasaki A; Ogawa T; Inagaki N; Shigeta H; Ohue Y; Tasaka T; Kitanaka A; Kubota Y; Tanaka T; Ishida T; Miyake M
Ann Hematol; 2008 Oct; 87(10):837-45. PubMed ID: 18553082
[TBL] [Abstract][Full Text] [Related]
27. Severity of oral mucositis in patients undergoing hematopoietic cell transplantation and an oral laser phototherapy protocol: a survey of 30 patients.
Eduardo FP; Bezinelli L; Luiz AC; Correa L; Vogel C; Eduardo CP
Photomed Laser Surg; 2009 Feb; 27(1):137-44. PubMed ID: 18699729
[TBL] [Abstract][Full Text] [Related]
28. N-acetyl cysteine for prevention of oral mucositis in hematopoietic SCT: a double-blind, randomized, placebo-controlled trial.
Moslehi A; Taghizadeh-Ghehi M; Gholami K; Hadjibabaie M; Jahangard-Rafsanjani Z; Sarayani A; Javadi M; Esfandbod M; Ghavamzadeh A
Bone Marrow Transplant; 2014 Jun; 49(6):818-23. PubMed ID: 24614837
[TBL] [Abstract][Full Text] [Related]
29. Management of oral mucositis at European transplantation centres.
Stone R; Potting CM; Clare S; Uhlenhopp M; Davies M; Mank A; Quinn B;
Eur J Oncol Nurs; 2007; 11 Suppl 1():S3-9. PubMed ID: 17540296
[TBL] [Abstract][Full Text] [Related]
30. Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation.
Bhatt V; Vendrell N; Nau K; Crumb D; Roy V
J Oncol Pharm Pract; 2010 Sep; 16(3):195-204. PubMed ID: 19910393
[TBL] [Abstract][Full Text] [Related]
31. Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation.
Nguyen DT; Shayani S; Palmer J; Dagis A; Forman SJ; Epstein J; Spielberger R
Support Care Cancer; 2015 Nov; 23(11):3141-7. PubMed ID: 25791390
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of oral cryotherapy on oral mucositis prevention in patients with hematological malignancies undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials.
Wang L; Gu Z; Zhai R; Zhao S; Luo L; Li D; Zhao X; Wei H; Pang Z; Wang L; Liu D; Wang Q; Gao C
PLoS One; 2015; 10(5):e0128763. PubMed ID: 26024220
[TBL] [Abstract][Full Text] [Related]
33. Ice-cream used as cryotherapy during high-dose melphalan conditioning reduces oral mucositis after autologous hematopoietic stem cell transplantation.
Jasiński M; Maciejewska M; Brodziak A; Górka M; Skwierawska K; Jędrzejczak WW; Tomaszewska A; Basak GW; Snarski E
Sci Rep; 2021 Nov; 11(1):22507. PubMed ID: 34795377
[TBL] [Abstract][Full Text] [Related]
34. Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain.
Demarosi F; Lodi G; Soligo D; Sardella A; Volpe AD; Carrassi A; Deliliers GL
Bone Marrow Transplant; 2004 Jun; 33(12):1247-51. PubMed ID: 15094750
[TBL] [Abstract][Full Text] [Related]
35. Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.
Shouval R; Kouniavski E; Fein J; Danylesko I; Shem-Tov N; Geva M; Yerushalmi R; Shimoni A; Nagler A
Eur J Haematol; 2019 Oct; 103(4):402-409. PubMed ID: 31332836
[TBL] [Abstract][Full Text] [Related]
36. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation.
Bolwell BJ; Kalaycio M; Sobecks R; Andresen S; Kuczkowski E; Bernhard L; Lomax R; Kohuth J; Mendiola S; Rybicki L; Pohlman B
Bone Marrow Transplant; 2002 Nov; 30(9):587-91. PubMed ID: 12407433
[TBL] [Abstract][Full Text] [Related]
37. Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy.
Eduardo Fde P; Bezinelli LM; de Carvalho DL; Lopes RM; Fernandes JF; Brumatti M; Vince CS; de Azambuja AM; Vogel C; Hamerschlak N; Correa L
Pediatr Transplant; 2015 May; 19(3):316-25. PubMed ID: 25677170
[TBL] [Abstract][Full Text] [Related]
38. Reliability and efficacy of palifermin in prevention and management of oral mucositis in patients with acute lymphoblastic leukemia: a randomized, double-blind controlled clinical trial.
Lucchese A; Matarese G; Manuelli M; Ciuffreda C; Bassani L; Isola G; Cordasco G; Gherlone E
Minerva Stomatol; 2016 Feb; 65(1):43-50. PubMed ID: 26862696
[TBL] [Abstract][Full Text] [Related]
39. A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation.
Elad S; Ackerstein A; Bitan M; Shapira MY; Resnick I; Gesundheit B; Cohen Y; Diss O; Barak D; Dray L; Or R
Bone Marrow Transplant; 2006 Apr; 37(8):757-62. PubMed ID: 16518424
[TBL] [Abstract][Full Text] [Related]
40. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
